<DOC>
	<DOCNO>NCT02391012</DOCNO>
	<brief_summary>Fecal microbial treatment ( FMT ) treatment utilizes microbiota healthy intestine probiotic preparation . The feces healthy individual fluidized inserted intestinal tract sick individual , assume healthy flora colonize cure intestine . There report efficacy treatment inflammatory bowel disease currently number small . aim : To investigate whether use FMT bring improvement colitis IBD patient . Methods : The patient undergo full colonoscopy , stool preparation infuse colonoscope withdrawal instrument .</brief_summary>
	<brief_title>Fecal Transplantation Inflammatory Bowel Disease</brief_title>
	<detailed_description>Back ground : intestinal microbiota central role disease pathogenesis , either form `` permissive '' role direct pathogenic cause . Clostridium difficile colitis ; irritable bowel syndrome ( IBS ) IBD connect disturbance equilibrium intestinal microbiome . But causative mechanism yet know . ( 5-10 ) . Various bacteria include lactobacillus acidophilus bifidobacterium bifidus empirically use treatment many intestinal ailment . The cause inflammatory bowel disease unknown evidence gather excessive immune reaction intestinal immune system microflora combine genetic predisposition responsible chronic inflammation . Fecal microbial treatment ( FMT ) treatment utilizes microbiota healthy intestine probiotic preparation . The feces healthy individual fluidized inserted intestinal tract sick individual , assume healthy flora colonize cure intestine . Previous work show success fecal transplantation treatment clostridium difficile colitis . There also report efficacy treatment inflammatory bowel disease currently number small . A review Anderson et al describes 17 study report treatment IBD FMT . ( 12 ) . In 9 case do treat IBD 8 case intestinal infection IBD patient . Altogether 41 case report , In FMT insert nasogastric tube directly duodenum , colonoscopy enema . A significant clinical improvement report 19/25 patient . 13/17 stop IBD treatment , 15/24 enter full clinical remission . In 15 patient treated infection treatment successful . No sever adverse effect report , Fever develop 8 case one case exacerbation colitis treatment . Primary aim : To investigate whether use FMT bring improvement least 2 point partial mayo score ulcerative colitis patient , 70 point CDAI patient Crohn 's colitis . One month FMT . Improvement define : For Ulcerative colitis : decrease least 2 point partial mayo score , decrease least 1 point endoscopic Mayo score . For Crohn 's disease : A decrease least 70 point Crohn 's disease activity index ( CDAI ) . Materials method : Study population : 40 patient age 18-80 year , histological endoscopic diagnosis ulcerative colitis crohn 's colitis respond either thiopurines tumor necrosis factor ( TNF ) inhibitor . Exacerbation define partial mayo score high 3 , either CRP high 0.5 endoscopic mayo score &gt; 1 ulcerative colitis CDAI high 220 C reactive protein ( CRP ) high 0.5 Crohn 's colitis . Stool donate patient choice either relative , preferably partner minimize possible transference infective agent , alternatively sample order `` open biom '' . Endoscopic disease activity define follow : Endoscopic Mayo score : - Normal inactive disease : 0 - Mild disease ( erythema , decrease vascular pattern , mild friability ) : 1 - Moderate disease ( marked erythema , absent vascular pattern , friability , erosion ) : 2 - Severe disease ( spontaneous bleeding , ulceration ) : 3 Simple endoscopic score Crohns disease ( SES-CD ) : Segments intestine : Rectum , Sigmoid leave colon , Transverse colon , Right colon , Ileum segment Presence : ulcer , Ulcerated surface , Affected surface , Presence narrowing , number affect segment evaluate total score sum , The SES-CD calculate follow : TOTAL - 1.4 X ( number affect segment ) = E-CDI Inclusion criterion Donor : 1 . Signed informed consent 2 . Basically healthy , hospitalization last 6 month , active malignant disease ( exclusion Basal cell skin tumor treat ) . 3 . No antibiotic treatment last 6 month 4 . Preferably partner patient , relative leave house 5 . No febrile illness last month 6 . Normal laboratory test include : blood count , liver kidney function , negative hepatitis A immunoglobulin M ( IgM ) , negative hepatitis C antibody , negative HbsAg , negative HIV , human T-lymphotropic virus ( HTLV I/II ) , negative venereal disease research laboratory ( VDRL ) . 7 . Stool test : Negative stool culture , negative C. difficile toxin ( A B ) . Negative parasite microscopy . Fecal calprotectin . Patient : 1 . Signed informed consent 2 . Inflammatory bowel disease diagnose least 3 month ago 3 . Failure either one immunomodulator least 3 month duration , TNF inhibitor full induction treatment , intolerance either drug . 4 . Currently active disease , partial Mayo score ≥4 ulcerative colitis ( UC ) , CDAI ≥200 Crohn 's disease ( CD ) . 5. negative HIV , HTLV I/II , negative stool culture , Negative C diff toxin , negative cytomegalovirus ( CMV ) Treatment protocol : 1 . Both donor recipient sign inform consent 2 . Both donor recipient mention laboratory test , investigator verify result negative . 3 . Recipient prepare colonoscopy 3 liter polyethylene glycol accord routine protocol . 4 . The donor bring day stool , alternatively , preparation `` open biom '' use . 5 . 200 gr stool mixed sterile 200ml sodium chloride ( NACL ) 0.9 % filter exclude large particle . 6 . The patient undergo full colonoscopy , stool preparation infuse colonoscope withdrawal instrument . 7 . If improvement within 7 day , patient offer option another FMT use enema prepared similar manner . 8 . Patients instruct maintain high fiber diet , Follow : On first colonoscopy : Exact description length involve segment + Mayo visual score UC simple endoscopic score - CD ( SES -CD ) Crohn 's disease . 2 biopsy colonic segment : Rt colon , transverse colon , leave colon , rectum . Weekly partial Mayo score Harvey Bradshow Index ( HBI ) first month , month 6 month . After 6 month repeat colonoscopy + biopsy + stool sample . Colonoscopy complete include segment inflame first colonoscopy . At time colonoscopy blood test include complete blood count ( CBC ) , liver kidney function , CRP , fecal calprotectin . Microbiota profile : 1 . From donor recipient FMT . 2 . From recipient : one month 6 month FMT . Stool sample frozen immediately -20° transferred laboratory microbiota analysis .</detailed_description>
	<mesh_term>Intestinal Diseases</mesh_term>
	<mesh_term>Inflammatory Bowel Diseases</mesh_term>
	<criteria>1 . Signed informed consent 2 . Inflammatory bowel disease diagnose least 3 month ago 3 . Failure either one immunomodulator least 3 month duration , TNF inhibitor full induction treatment , intolerance either drug . 4 . Currently active disease , partial Mayo score ≥4 ulcerative colitis , CDAI ≥200 CD . 5. negative HIV , HTLV I/II , negative stool culture , Negative C diff toxin , negative CMV 1 . No informed consent 2 . Non active inflammatory bowel disease . 3 . Active infection either donor recipient ,</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Ulcerative colitis</keyword>
	<keyword>Crohns disease</keyword>
	<keyword>Microbial transplantation</keyword>
</DOC>